Mary Beth Ritchey

Mary Beth Ritchey has a diverse work experience in the field of epidemiology and pharmacoepidemiology. Mary Beth currently holds the position of Chief Scientific Officer at CERobs Consulting LLC since August 2023. Prior to this, they worked as an Associate Research Professor and Adjunct Faculty at Rutgers Center for Pharmacoepidemiology and Treatment Science from June 2018 to May 2020. Mary Beth also served as an Associate Editor at Pharmacoepidemiology and Drug Safety starting from October 2018.

In terms of government experience, Mary Beth Ritchey worked at the FDA as the Chief Epidemiologist, CDRH from July 2022 to August 2023. Mary Beth also served as an Associate Division Director (Epidemiology) at the FDA from April 2009 to December 2012.

Their experience in the industry includes roles such as Principal and Owner at Med Tech Epi, LLC from February 2020 to July 2022, Director of Epidemiology, Medical Devices & Real-World Evidence at RTI Health Solutions from January 2016 to February 2020, Senior Epidemiologist at Procter & Gamble from June 2014 to December 2015, and Associate Principal Scientist / Associate Director (Epidemiology) at Merck from January 2013 to May 2014.

Overall, Mary Beth Ritchey has a strong background in epidemiology and pharmacoepidemiology with extensive experience in academia, government, and industry.

Mary Beth Ritchey has a diverse education history. Mary Beth obtained a PhD and MSPH in Epidemiology from the University of North Carolina at Chapel Hill from 2004 to 2009. Prior to that, they completed their BSN in Nursing at the same university from 2002 to 2004. Mary Beth also holds a BS degree in Chemistry and Pharmacology from Duke University, which they earned from 1997 to 2001.